Second phase I trial to investigate two twice-daily controlled release formulations of DM-1992 (levodopa/carbidopa) compared with a sustained release generic forumation, Sinemet, in patients with Parkinson's disease.
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2012
At a glance
- Drugs Levodopa/carbidopa; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Pharmacokinetics
- 28 Feb 2012 Results published in Clinical Neuropharmacology.
- 07 Feb 2011 Preliminary results have been reported in a Depomed media release. Further results are expected to be presented at an upcoming conference in 2011.
- 07 Feb 2011 Status changed from planning to completed.